C20H22N8O3
425.5 g/mol
원료의약품위험
Deucravacitinib
CAS1609392-27-9
용도 분류
원료의약품
화합물 분류
헤테로사이클
주요 용도
의약 원료
Deucravacitinib is an oral selective tyrosine kinase 2 (TYK2) inhibitor that binds to the regulatory domain of TYK2, distinguishing it from other Janus kinase inhibitors. It is an active pharmaceutical ingredient used in pharmaceutical manufacturing.
pharmaceutical raw material for manufacturing TYK2 inhibitor-based productscompound used in pharmaceutical research and development
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1609392-27-9
관련 화합물
유사구조 유사유사도 0.80
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
CAS2245111-18-4
Pharmaceutical intermediate for deucravacitinib
유사구조 유사유사도 0.79
Zinc(II) 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylate
CAS2245111-19-5
Zinc salt pharmaceutical intermediate
유사구조 유사유사도 0.75
6-chloro-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
CAS1609394-23-1
n.a
참고동일 카테고리
SEL120-34A HCl
CAS1609452-30-3
CDK8/19 inhibitor
참고동일 카테고리
Silodosin
CAS160970-54-7
active pharmaceutical ingredient
참고동일 카테고리
1-(3-Hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-2,3-dihydro-1H-indole-7-carboxamide
CAS160970-64-9
active pharmaceutical ingredient
참고동일 카테고리
Desisopropyl butyl torsemide
CAS160972-33-8
pharmaceutical impurity reference standard
안전 참조
위험
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
식별자
IUPAC 이름
6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
InChIKey
BZZKEPGENYLQSC-FIBGUPNXSA-N
SMILES
[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4
동의어 목록 (17)
- Deucravacitinib (JAN/USAN)
- (BMS-986165)
- Deucravacitinib
- Deucravacitinib(BMS986165)?
- Sotyktu
- Sotyktu (TN)
- Tyk2-IN-4
- Tyk2-IN-4(BMS986165)
- WHO 11342